Interferon therapy for Ph1-positive chronic myelogenous leukaemia patients relapsing after T-cell depleted allogeneic bone marrow transplantation

Eur J Cancer. 1991:27 Suppl 4:S28-30. doi: 10.1016/0277-5379(91)90564-t.

Authors

W Arcese¹, F R Mauro, M Screnci, G Alimena, F Lo Coco, A P Iori, M R de Cuia, P Fazi, E Montefusco, F Mandelli

Affiliation

¹ Department of Human Biopathology, University La Sapienza, Rome, Italy.

PMID: 1799471
DOI: 10.1016/0277-5379(91)90564-t

No abstract available

MeSH terms

Adolescent
Adult
Bone Marrow Transplantation*
Child
Female
Humans
Interferon alpha-2
Interferon-alpha / therapeutic use*
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / mortality
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / surgery
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / therapy*
Male
Philadelphia Chromosome
Recombinant Proteins

Substances

Interferon alpha-2
Interferon-alpha
Recombinant Proteins